Annie Jullien-Pannelay is consulting the Life-Sciences Group at Etradex Corp.
Ms. Jullien-Pannelay has several years of experience from the asset management and venture capital sectors. She most recently worked in New York, as buy side analyst on healthcare growth stocks with Khandaker, Partners and Co.
Before moving to New York, she worked in Hong Kong at BNP Paribas Asset Management, where she led expansion projects over Asia, hence developing knowledge of cultural business differences. She gained experience in investment in Paris, France at Matignon Investissement et Gestion, performing valuations and analysis for Life Sciences investment proposals, and with Bryan, Garnier and Co. focusing on public pharmaceutical companies.
In the scientific field, she worked at LFB (Fractionnement et Biotechnologies) in Paris to prepare the launch of a specific international development program for some of its products. She wrote her doctoral thesis on cost-clinical benefits of different formulations of antifungal drugs while she was Resident Pharmacist at the Nice hospital Complex, France.
Her experience also includes basic research, with CNRS in Montpellier, France, as research assistant, resolving structure of peptides through NMR (Nuclear Magnetic Resonance).
Ms. Jullien-Pannelay graduated in 2005 from ESSEC in Paris, France, MBA program and in 2003 from the Montpellier Pharmacy Faculty in Montpellier, France. Pharmaceutical Doctorate with honors.